anx_II__para_3__continuation__8
91/666/EEC: Council Decision of 11 December 1991 establishing Community reserves of foot-and-mouth disease vaccines · European Union
the concentrated product containing the inactivated antigen should be in a volume at least 100 times less than that used for formulation of conventional vaccines. The producer must indicate the number of vaccine doses per volume unit of concentrated material; and
← anx_II__para_3__continuation__7 · All articles · anx_II__para_3__continuation__9 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-08 · Text as adopted (Official Journal); later amendments are not incorporated in this text.